Prof. Xu Tao is Vice president and professor of University of Chinese Academy of Sciences (UCAS), Director of Bureau of Frontier Science and Education, CAS, also a Principal Investigator at Institute of Biophysics, CAS，Member of CAS. He received his PhD in 1996 from Huazhong University of Science and Technology. From 1996 to 2000, he undertook postdoctoral work first with Erwin Neher at the Max-Planck Institute for Biophysical Chemistry and then with Bertil Hille at the University of Washington. He was nominated as Cheung Kong Scholar Chair Professor in 2000, at the same time, he won the National Science Fund for Distinguished Young Scholars. Prof. Xu has won the The Li Foundation Heritage Prize in 2001 and 2002.Since 2000, he has led his research group in Huazhong University of Science and Technology, then in the Institute of Biophysics, CAS, focusing on the molecular determinant and regulation of vesicle exocytosis, translocation of GLUT4 storage vesicle; gating mechanism of Ca2+ release-activated Ca2+ channel gating, modulation and its stoichiometry; development of super-resolution correlative light-electron microscopy.
Duanqing Pei, a foreign member of the European Molecular Biology Organization (EMBO), and Head of the Expert Committee on "Key Special Programs for Stem Cells and Translational Research" of the Ministry of Science and Technology (MOST), is the Deputy Director of Guangzhou Regenerative Medicine and Health Guangdong Laboratory. He is also a member of the Human Gene Editing Research Council and the Clinical Translation Committee of the International Society for Stem Cell Research (ISSCR). After receiving his Ph.D. in Molecular Cell and Developmental Biology from the University of Pennsylvania in 1991, he worked as a postdoctoral fellow at the University of Michigan (US) from 1991 to 2004, until tenured in the Department of Pharmacology at the University of Minnesota as an assistant professor and (tenured) associate professor. Dr. Pei has won the 2nd Class of the National Natural Science Awards twice.
Prof. Song obtained his M.D. and Ph.D. from Sun Yat-sen University, and trained as physician at Sun Yat-sen Memorial Hospital, SYSU. He had postdoc training at Essen University Hospital in Germany and Harvard Medical School from 1999 to 2004. His early publication “RNA interference targeting Fas protects mice from fulminant hepatitis” in Nature Medicine was the first to report that siRNA could be used therapeutically in whole animal disease model, and selected as one of the “Ten breakthroughs of the year 2003” by Science. After setting up his lab at Sun Yat-sen University in China, he has focused his research on the microenvironment of malignant tumors, mainly on breast cancers, and unraveled the regulatory mechanisms of non-coding RNAs (ncRNAs) related to tumor microenvironment. 2007, Prof. Song was elected as Cheung Kong Scholars Programme Distinguished Professor. Prof. Song was nominated as the president of Sun Yat-Sen Memorial Hospital in 2016, and servers as dean of Zhongshan School of Medicine from 2017. 2019 Prof. Song is selected as Member of CAS.